Literature DB >> 3816102

Colchicine suppression of local inflammation due to calcinosis in dermatomyositis and progressive systemic sclerosis.

D Fuchs, L Fruchter, B Fishel, M Holtzman, M Yaron.   

Abstract

Two girls, one with progressive systemic sclerosis and a second with dermatomyositis, developed calcinosis in the skin of the prepatellar area. Calcinosis was accompanied by local inflammation and skin ulceration. Oral colchicine therapy in a dosage of 1 mg per day was followed within two months by significant regression of local inflammation and healing of the skin ulcers.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3816102

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  13 in total

Review 1.  The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.

Authors:  Mark F Hoeltzel; Edward J Oberle; Angela Byun Robinson; Arunima Agarwal; Lisa G Rider
Journal:  Curr Rheumatol Rep       Date:  2014-12       Impact factor: 4.592

Review 2.  The current treatment of scleroderma.

Authors:  G F Oliver; R K Winkelmann
Journal:  Drugs       Date:  1989-01       Impact factor: 9.546

Review 3.  Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards.

Authors:  Dinesh Khanna; Daniel E Furst; Yannick Allanore; Sangmee Bae; Vijay Bodukam; Philip J Clements; Maurizio Cutolo; Laszlo Czirjak; Christopher P Denton; Oliver Distler; Ulrich A Walker; Marco Matucci-Cerinic; Ulf Müller-Ladner; James R Seibold; Manjit Singh; Alan Tyndall
Journal:  Rheumatology (Oxford)       Date:  2014-08-13       Impact factor: 7.580

Review 4.  Treatment of Calcinosis in Juvenile Dermatomyositis.

Authors:  Ovgu Kul Cinar; Charalampia Papadopoulou; Clarissa A Pilkington
Journal:  Curr Rheumatol Rep       Date:  2021-02-08       Impact factor: 4.592

5.  Electric shock wave lithotripsy (ESWL) as a pain control measure in dermatomyositis with calcinosis cutis-old method, new discovery.

Authors:  Alice Y K Chan; Edmund Li
Journal:  Clin Rheumatol       Date:  2004-11-24       Impact factor: 2.980

Review 6.  Subcutaneous calcinosis: Is it different between systemic sclerosis and dermatomyositis?

Authors:  Antonia Valenzuela; Lorinda Chung
Journal:  J Scleroderma Relat Disord       Date:  2021-10-28

Review 7.  Treatment of systemic sclerosis.

Authors:  T A Medsger
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 8.  Familial tumoral calcinosis and the role of O-glycosylation in the maintenance of phosphate homeostasis.

Authors:  Ilana Chefetz; Eli Sprecher
Journal:  Biochim Biophys Acta       Date:  2008-10-25

Review 9.  Juvenile-onset clinically amyopathic dermatomyositis: an overview of recent progress in diagnosis and management.

Authors:  Hobart W Walling; Pedram Gerami; Richard D Sontheimer
Journal:  Paediatr Drugs       Date:  2010       Impact factor: 3.022

Review 10.  Tumoral calcinosis: new insights for the rheumatologist into a familial crystal deposition disease.

Authors:  Eli Sprecher
Journal:  Curr Rheumatol Rep       Date:  2007-06       Impact factor: 4.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.